Desipramine Treatment for Cocaine Dependence in Buprenorphine- or Methadone-treated Patients: Baseline Urine Results as Predictor of Response

REFERENCES

• Lavori PW, Bloch DA, Bridge PT, , et al. Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDA/VA/SU working group on design and analysis. J Clin Psychopharmacol. 1999;19:246–256.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Power ME, Bryant K, , et al. One-year follow-up status of treatment-seeking cocaine abusers: psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis. 1993;181:71–79.
   PubMed Web of Science ®Google Scholar
• Siqueland L, Crits-Christoph P, Gallop R, , et al. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict. 2002;11:24–40.
   PubMed Web of Science ®Google Scholar
• Moeller FG, Dougherty DM, Barratt ES, , et al. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat. 2001;21:193–198.
   PubMed Web of Science ®Google Scholar
• McMahon RC, Kouzekanani K, Malow RM.. A comparative study of cocaine-treatment completers and dropouts. J Subst Abuse Treat. 1999;16:17–22.
   PubMed Web of Science ®Google Scholar
• Reiber C, Ramirez A, Parent D, , et al. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug Alcohol Depend. 2002;68:35–48.
   PubMed Web of Science ®Google Scholar
• Alterman AI, Kampman K, Boardman CR, , et al. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend. 1997;46:79–85.
   PubMed Web of Science ®Google Scholar
• Ehrman RN, Robbins SJ, Cornish JW. Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend. 2001;62:1–7.
   PubMed Web of Science ®Google Scholar
• Oliveto AH, Feingold A, Schottenfeld R, , et al. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs. methadone. Arch Gen Psychiatry. 1999;56:812–820.
   PubMedGoogle Scholar
• Kosten TR, Kleber HD, Morgan C, Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 1989;44:887–892.
   PubMed Web of Science ®Google Scholar
• Schottenfeld RS, Pakes J, Ziedonis D, , et al. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry. 1993;34:66–74.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Morgan CM, Falcione J, , et al. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry. 1992;49:894–898.
   PubMed Web of Science ®Google Scholar
• McGlothlin WH, Anglin MD. Long-term follow-up of clients with high- and low-dose methadone programs. Arch Gen Psychiatry. 1981;31:1055–1063.
   Google Scholar
• Hargreaves WA. Methadone Dose and Duration of Treatment: Research on the Treatment of Narcotic Addiction State of the Art. Rockville, Md.: NIDA, Alcohol, Drug Abuse, and Mental Health Services; 1983.
   Google Scholar
• Hatziandreu EJ, Sisk JE, Hughes R. The effectiveness of drug abuse treatment: implications for controlling AIDS/HIV infection. Office of Technology Assessment Series on AIDS-Related Issues; 1990..
   Google Scholar
• Kosten TR, Schottenfeld RS, Ziedonis D, , et al. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993;181:358–364.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JBW, Givvons M, , et al. Structural Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Association Press; 1990.
   Google Scholar
• McLellan AT, Cacciola J, Kushner H, , et al. The fifth edition of the Addiction Severity Index: cautions, additions, and normative data. J Subst Abuse. 1992;9:461–480.
   Google Scholar
• Bryk AS, Raudenbush SW. Application of hierarchical linear models to assessing change. Psychol Bull. 1987;101:147–158.
   Web of Science ®Google Scholar
• Gibbons RD, Hedeker D, Elkin I, , et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data: application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993;50:739–750.
   PubMed Web of Science ®Google Scholar
• Strain EC, Stitzer ML, Liebson IA, , et al. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry. 1994;151:1025–1030.
   PubMed Web of Science ®Google Scholar
• Schottenfeld RS, Pakes JR, Oliveto A, , et al. Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997;54:713–720.
   PubMed Web of Science ®Google Scholar
• George TP, Chawarski MC, Pakes J, , et al. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry. 2000;47:1080–1086.
   PubMed Web of Science ®Google Scholar
• Compton PA, Ling W, Charuvastra VC, , et al. Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence. J Addict Dis. 1995;14:97–114.
   PubMed Web of Science ®Google Scholar
• Arndt IO, Dorozynsky L, Woody GE, , et al. Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry. 1992;49:888–893.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Gawin FH, Morgan CH, , et al. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. Am J Drug Alcohol Abuse. 1990;16:329–336.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Gonzalez J, Poling J, Kosten TR. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse. 2003;29(4):713–727.
   PubMed Web of Science ®Google Scholar